Nasdaq Ndra News Today

ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) and Heyu Biological Technology (OTCMKTS:HYBT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Profitability This table compares ENDRA […]

ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) and Invitae (NYSE:NVTA – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Insider and Institutional Ownership 6.0% of ENDRA […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 69,200 shares, a growth of 61.7% from the July 31st total of 42,800 shares. Currently, 0.9% of the shares of the stock […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Free Report) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 74,500 shares, an increase of 40.0% from the May 31st total of 53,200 shares. Approximately 1.0% of the shares of the company are […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating)’s share price rose 2% on Friday . The stock traded as high as $1.51 and last traded at $1.50. Approximately 97,821 shares traded hands during trading, an increase of 208% from the average daily volume of 31,717 shares. The stock had previously closed at $1.47. Analyst Upgrades […]

ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) will issue its quarterly earnings data after the market closes on Monday, May 15th. Analysts expect the company to announce earnings of ($1.02) per share for the quarter. ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) last issued its quarterly earnings results on Tuesday, March 14th. The company reported […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) Director Anthony Digiandomenico bought 83,333 shares of the firm’s stock in a transaction that occurred on Tuesday, May 2nd. The stock was bought at an average price of $1.20 per share, with a total value of $99,999.60. Following the transaction, the director now directly owns 102,434 shares […]

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) Director Anthony Digiandomenico acquired 83,333 shares of the company’s stock in a transaction dated Tuesday, May 2nd. The shares were bought at an average price of $1.20 per share, for a total transaction of $99,999.60. Following the purchase, the director now owns 102,434 shares in the company, […]

HC Wainwright reaffirmed their buy rating on shares of ENDRA Life Sciences (NASDAQ:NDRA – Get Rating) in a report released on Friday morning, Benzinga reports. They currently have a $9.00 price objective on the stock. HC Wainwright also issued estimates for ENDRA Life Sciences’ Q1 2023 earnings at ($1.02) EPS, Q2 2023 earnings at ($0.70) […]

Equities analysts predict that ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Rating) will announce earnings per share (EPS) of ($0.05) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for ENDRA Life Sciences’ earnings. ENDRA Life Sciences reported earnings of ($0.08) per share in the same quarter last year, which […]